国邦医药：截至10月累计回购1.03亿元股份用于激励

Core Viewpoint - The company announced a share repurchase plan aimed at enhancing employee stock ownership and equity incentives, with a total repurchase amount expected to be between 100 million to 200 million yuan [1] Group 1 - The share repurchase will be conducted through centralized bidding and is set to last until March 10, 2026 [1] - As of October 31, 2025, the company has repurchased a total of 5.3753 million shares, which represents 0.96% of the total share capital [1] - The highest transaction price recorded during the repurchase was 19.88 yuan per share, while the lowest was 18.61 yuan per share, with a total expenditure of 103 million yuan [1]